Laetrile
This article was originally published in The Tan Sheet
Executive Summary
Christian Brothers Contracting will cease manufacturing, processing and distributing amygdalin products under a consent decree signed Nov. 16, FDA announces. The New York-based firm used the Internet to market and sell the products - also referred to as laetrile, vitamin B17 or apricot kernels - for use in cancer therapy despite FDA warnings, the agency alleges. A Brooklyn federal court entered a preliminary injunction against Christian Brothers and its president in April